A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

NCT07142707 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: MBX 4291
DRUG: Placebo

Sponsor

MBX Biosciences